Syndromic Sensorineural Deafness Due to Combined Oxidative Phosphorylation Defect (COXPD)

Syndromic sensorineural deafness due to combined oxidative phosphorylation defect (COXPD) is a very rare genetic mitochondrial disease. In this condition, tiny “power stations” inside cells (mitochondria) do not make enough energy using the oxidative phosphorylation system. Because the inner ear, brain, liver and kidneys all need a lot of energy, they can be badly affected. Babies are often born with permanent sensorineural hearing loss, high blood lactic acid, and sometimes liver and kidney problems.

In many families, this disease happens when both copies of a gene important for mitochondrial function (for example MRPS7 or other oxidative phosphorylation genes) are changed by mutations. The disease is autosomal recessive, which means both parents are usually healthy carriers, but the child gets both changed copies. The illness is lifelong and can be mild or very severe. Some children mainly have hearing loss; others also have big problems with growth, muscles, feeding, seizures, or organ failure.

Right now there is no single “cure” tablet or injection that fixes COXPD. Treatment is based on three goals: support hearing and communication, support organs and nutrition, and try vitamin or cofactor “mitochondrial cocktails” that may help cells work a little better. Because strong proof is limited, all medicines and supplements should be used only under a specialist in mitochondrial disease and a pediatric or adult metabolic team.

Syndromic sensorineural deafness due to combined oxidative phosphorylation defect is a very rare inherited mitochondrial disease. It belongs to a group of disorders called combined oxidative phosphorylation deficiencies (often shortened to COXPD). In this disease, the tiny “power stations” inside cells, called mitochondria, cannot make enough energy (ATP) because several steps of the oxidative phosphorylation chain do not work properly. This low energy production especially hurts organs that need a lot of energy, such as the inner ear, liver, kidneys, brain and muscles [1].

In this condition, children are born with or soon develop sensorineural hearing loss. “Sensorineural” means the damage is in the inner ear (cochlea) or the hearing nerve, not in the outer or middle ear. Because the same mitochondrial problem affects other body systems, the hearing loss is called “syndromic” (hearing loss plus other medical problems). Many patients also have low blood sugar (hypoglycemia), high blood lactic acid (lactic acidemia), and problems with liver and kidney function that can slowly worsen over time [1] [2].

One well-described form is called “combined oxidative phosphorylation deficiency 34” (COXPD34). It is caused by harmful changes (mutations) in a nuclear gene called MRPS7, which makes a protein needed for the mitochondrial ribosome, the part of mitochondria that helps build other mitochondrial proteins. This gene sits on chromosome 17q25.1. The disease is inherited in an autosomal recessive way, which means the child usually gets one faulty copy of the gene from each parent [2] [3].

Mitochondrial disorders are a broad group of conditions where the oxidative phosphorylation chain is not working correctly. Many of these diseases can cause sensorineural hearing loss, sometimes together with brain, muscle, eye, heart, or hormonal problems. Studies show that mitochondrial dysfunction and oxidative stress (too many harmful oxygen molecules) are central reasons for sensorineural hearing loss in both inherited and acquired forms [4] [5].

---

Other names

This condition has several other names in medical databases and papers. These names all point to the same or very closely related disease pattern: congenital sensorineural deafness together with combined oxidative phosphorylation deficiency. Doctors and researchers may use different names in different systems [1] [2] [3].

• Combined oxidative phosphorylation deficiency 34 (COXPD34) – disease ontology term DOID:0111497. [3]

• Syndromic sensorineural deafness due to combined oxidative phosphorylation defect – preferred name in some classification systems. [6]

• Syndromic sensorineural deafness due to COXPD – similar wording showing both deafness and mitochondrial problem. [3]

• Syndromic sensorineural hearing loss due to COXPD – another variant of the same phrase. [3]

• COXPD34; Deafness, hepatic and renal failure, lactic acidemia – name used in some neuromuscular and mitochondrial disease lists [7].

---

Types (clinical patterns)

Because this disease is extremely rare, there is no big official list of “types” like in some common conditions. But looking at published cases and mitochondrial disease reviews, doctors can describe several clinical patterns within syndromic sensorineural deafness related to combined oxidative phosphorylation defects [1] [4] [5].

1. Classic COXPD34 pattern – congenital sensorineural deafness plus lactic acidemia, hypoglycemia, and progressive liver and kidney failure in early childhood. [1] [2]

2. Predominantly hepatic–renal form – same basic mitochondrial defect, but liver and kidney problems are more obvious, and hearing loss may be noticed slightly later or be overshadowed by organ failure. [7]

3. Deafness-dominated form – sensorineural hearing loss is the main or first sign, while other organs are relatively less affected or show milder changes. This pattern is also seen in COXPD54 and other COXPD types with strong hearing involvement [8] [9].

4. Multisystem early-onset form – severe disease where hearing loss comes with developmental delay, brain white matter changes (leukodystrophy), muscle weakness, and sometimes ovarian problems in females, similar to some PRORP-related COXPD phenotypes [8] [9].

5. Variable or evolving phenotype – in some cases, the pattern of symptoms changes over time as organs become more stressed, so hearing loss may appear early, and later liver, kidney, or brain problems become more evident [1] [4].

---

Causes (Mechanisms and factors)

Remember: for this named disease, the core cause is inherited changes in genes that control mitochondrial oxidative phosphorylation. The 20 “causes” below describe specific genetic defects and biological mechanisms that together explain why the syndrome happens and why it looks the way it does [1] [3] [4] [5].

1. MRPS7 gene mutation (primary cause) – In COXPD34, harmful variants in the MRPS7 gene disturb the mitochondrial ribosome, which is the machinery that makes mitochondrial proteins. Without enough normal MRPS7 protein, many parts of the respiratory chain (complexes I, III, and IV) are not produced properly, leading directly to energy failure in cells [2] [3].

2. Combined respiratory chain complex defects – Because the mitochondrial ribosome is disturbed, complexes I, III, and IV are all reduced. These complexes pass electrons and pump protons to make ATP. When several complexes are weak, the whole oxidative phosphorylation chain is slowed, and cells cannot meet their energy needs [1] [4].

3. Impaired ATP production in cochlear hair cells – The inner ear hair cells work constantly and use a lot of ATP. When oxidative phosphorylation is weak, these cells cannot maintain ion gradients and normal function, and they gradually die, causing permanent sensorineural deafness [4] [5].

4. Excess reactive oxygen species (oxidative stress) – Faulty electron transport leads to “leakage” of electrons and formation of reactive oxygen species (ROS). These damage mitochondrial membranes, DNA, and proteins, especially in cochlear cells and other high-energy tissues, worsening hearing loss and organ failure [4] [5].

5. Mitochondrial DNA stress and secondary mtDNA damage – Even though COXPD34 is driven by a nuclear gene, the chronic oxidative stress can also damage mitochondrial DNA. This secondary damage further reduces respiratory chain function, making the disease more severe over time [5] [10].

6. Vulnerability of cochlear cells to energy shortage – The cochlea needs steady energy to maintain the endocochlear potential (a special electrical environment in the inner ear). Any long-term drop in ATP directly harms hearing, so mitochondrial defects preferentially show up as sensorineural deafness [4] [5].

7. Autosomal recessive inheritance – Most reported families show autosomal recessive inheritance. Both parents are usually healthy carriers with one abnormal MRPS7 copy. When a child inherits both abnormal copies, the mitochondrial ribosome defect appears and causes the full syndrome [3] [7].

8. Consanguinity in some families – In some mitochondrial nuclear gene disorders, parents may be related (for example, cousins). This increases the chance that both parents carry the same rare mutation and have a child with the disease, although this is a risk factor, not the root molecular cause [1].

9. General mitochondrial disease background genes – Other genes involved in mitochondrial translation, assembly or maintenance can modify how severe the MRPS7 mutation looks in each person. These “modifier” genes can partly explain why symptoms differ even within the same family [4] [5].

10. Defective mitochondrial protein translation – Because MRPS7 helps the mitochondrial ribosome read mitochondrial RNA, its loss disrupts the translation of many mitochondrial proteins. This broad block in protein building is another core cause of the combined oxidative phosphorylation defect [2] [10].

11. Lactic acid buildup (lactic acidosis) – When mitochondria cannot produce enough ATP, cells switch to glycolysis, a less efficient pathway that produces lactic acid. High lactic acid in blood and tissues is both a marker and a contributor to the disease, causing acidosis and making organs such as the brain and muscles more stressed [1] [2].

12. Hypoglycemia due to energy failure – Liver and endocrine organs try to maintain normal blood sugar. When mitochondria are weak, glucose handling is abnormal, and the body can develop sudden or chronic low blood sugar. These episodes can damage the brain and worsen overall disease [1].

13. Hepatic mitochondrial dysfunction – Liver cells have many mitochondria. When their oxidative phosphorylation is defective, the liver cannot handle toxins, make proteins, or manage energy properly. This leads to elevated liver enzymes, jaundice, and eventually liver failure in some patients [1] [2].

14. Renal mitochondrial dysfunction – Kidney tubule cells also need a lot of ATP for reabsorbing salts and water. Mitochondrial failure in these cells can lead to progressive kidney dysfunction, protein loss in urine, and eventual renal failure, which is a key part of the COXPD34 description [1] [2].

15. Energy failure in brain and nerves – The brain and peripheral nerves require constant energy. Mitochondrial dysfunction may cause developmental delay, seizures, and abnormal muscle tone in some patients, contributing to the “syndromic” picture that includes deafness [4] [5].

16. Mitochondrial dysfunction in endocrine tissues – Some combined oxidative phosphorylation defects (such as COXPD54) involve ovarian insufficiency or other hormonal problems. Although this is not specific to every case, it shows that endocrine glands are another vulnerable site for mitochondrial energy failure [8] [9].

17. Stress from fever or infections – Intercurrent infections increase energy demand and may unmask or worsen symptoms such as hypoglycemia, lactic acidosis, and organ failure in children with mitochondrial disease. The underlying cause is still the genetic defect, but stress makes the weakness more visible [4] [5].

18. Possible sensitivity to certain drugs – Some medicines (for example, aminoglycoside antibiotics and some chemotherapy drugs) are known to damage mitochondria or hair cells. In someone with underlying COXPD, these drugs may worsen hearing loss or other symptoms, so they act as triggers on top of the genetic cause [4] [10].

19. Nutritional stress and fasting – Long fasting or poor feeding can be dangerous in mitochondrial disease, because the body already cannot manage energy properly. In COXPD34, fasting can trigger hypoglycemia or lactic acidosis episodes that worsen brain and organ injury [1].

20. Natural progression of mitochondrial damage with age – Over time, ongoing oxidative stress and repeated metabolic crises can gradually damage more cells and organs. This progression is not a separate cause but a time-related factor that explains why symptoms like deafness, liver failure, or kidney disease may become worse as the child grows [4] [5].

---

Symptoms

Individual patients can show different combinations of symptoms. However, reports of COXPD34 and related syndromic mitochondrial deafness show several common clinical features [1] [2] [4] [5] [6].

1. Congenital or very early-onset sensorineural hearing loss – Most children are born with significant hearing impairment or develop it in infancy. Parents may notice that the child does not startle to loud sounds or does not respond to voices. Audiology tests later confirm permanent sensorineural loss.

2. Delayed speech and language development – Because hearing loss is present from birth or early life, children often start speaking late or have unclear speech. Without early hearing support, language and communication may lag behind peers.

3. Recurrent or persistent hypoglycemia – Episodes of low blood sugar can cause irritability, sweating, shakiness, drowsiness, or even seizures. In COXPD34, hypoglycemia is a key feature and can appear during illness or fasting [1].

4. Lactic acidosis symptoms – High lactic acid can cause fast breathing, nausea, vomiting, abdominal pain, and general weakness. Blood tests often show raised lactate levels, confirming a mitochondrial energy problem [1] [2].

5. Failure to thrive and poor growth – Many affected children do not gain weight or height as expected. Feeding difficulties, poor appetite, repeated illness, and the heavy energy needs of the disease all contribute to slow growth.

6. Hepatomegaly (enlarged liver) – Doctors may find that the liver is larger than normal when they feel the child’s abdomen. This reflects liver involvement from mitochondrial dysfunction, lactic acidosis, and hypoglycemia [1].

7. Signs of liver dysfunction – Laboratory tests may show high liver enzymes, low albumin, or poor clotting. Clinically, there can be jaundice (yellow skin and eyes), easy bruising, swelling of legs or abdomen, and in severe cases signs of liver failure [2].

8. Signs of kidney dysfunction – As the renal involvement progresses, there may be swelling (edema), changes in urine amount, or abnormal salts in blood. Urine tests can show protein or other abnormalities, indicating kidney damage [1] [2].

9. Developmental delay – Some children show delayed motor milestones, such as late sitting or walking, and may have global developmental delay. This reflects brain and muscle energy shortage in a systemic mitochondrial disease [4] [5].

10. Low muscle tone (hypotonia) or muscle weakness – Babies may feel “floppy” when lifted, or older children may tire easily and have difficulty with stairs or running. Mitochondrial myopathy is common in oxidative phosphorylation disorders [4].

11. Seizures or abnormal movements – In some cases, energy failure in the brain can trigger seizures or movement disorders. Seizures may be especially common during fever or hypoglycemia episodes [4] [5].

12. Fatigue and exercise intolerance – Even if the child can walk and play, they may become tired faster than other children. Simple activities can cause exhaustion because their cells cannot increase ATP production properly [4].

13. Recurrent vomiting or feeding problems – Chronic lactic acidosis, liver dysfunction, and general illness can lead to poor feeding, vomiting, or abdominal discomfort, all of which worsen growth and energy balance [1].

14. Possible endocrine or hormonal problems – In some related COXPD forms (for example, COXPD54), girls may develop ovarian insufficiency or delayed puberty. While this is not clearly reported in all COXPD34 patients, it shows that endocrine symptoms can accompany mitochondrial deafness in some genetic subtypes [8] [9].

15. Progressive multi-organ failure in severe cases – Over time, combined liver and kidney failure, severe metabolic crises, or infections can lead to life-threatening multi-organ failure. Sadly, some reported children with severe COXPD34 have had poor outcomes in early childhood [1] [2].

---

Diagnostic tests

Because this is a very rare and complex disease, diagnosis usually needs a combination of clinical examination, hearing tests, metabolic tests, imaging, and finally genetic testing. Below are 20 key tests grouped by type. Not every patient needs every test, but many are used together in specialist centers [1] [4] [5] [7] [11].

Physical examination tests

1. General pediatric physical examination – The doctor checks weight, height, head size, vital signs, and overall appearance. They look for signs like poor growth, jaundice, enlarged liver, swelling, or abnormal breathing. This gives an overall picture of how many body systems are involved and helps guide further tests. [1]

2. Focused ear, nose, and throat (ENT) examination with otoscopy – An ENT specialist uses a lighted tool to look inside the ear and examine the eardrum and ear canal. In syndromic sensorineural deafness, the outer and middle ear usually look normal, which helps rule out conductive causes of hearing loss and points toward inner ear or nerve involvement. [4]

3. Neurological examination – The doctor checks muscle tone, strength, reflexes, coordination, and developmental milestones. Findings such as low tone, weakness, or developmental delay suggest that the mitochondrial defect is affecting the brain and nerves as well as hearing. [4] [5]

4. Nutritional and growth assessment – Measurements of weight-for-age, height-for-age, and head circumference, sometimes plotted on growth charts, help identify failure to thrive. Poor growth supports the suspicion of a chronic metabolic or mitochondrial disease and can influence nutritional and treatment planning. [1]

Manual tests

5. Bedside tuning fork tests (Rinne test) – A vibrating tuning fork is held near the ear and bone behind the ear to compare air and bone conduction. In sensorineural hearing loss, both air and bone conduction are reduced, but air conduction still appears better than bone. This simple manual test helps distinguish sensorineural from conductive hearing loss at the bedside. [4]

6. Weber tuning fork test – The tuning fork is placed on the forehead. In sensorineural hearing loss, the sound is heard better in the normal or less-affected ear. This manual test again supports that the problem lies in the inner ear or nerve, not the outer or middle ear. [4]

7. Simple behavioral hearing tests in infants – Doctors or audiologists watch how infants react to sounds (for example, turning the head or startling). These manual observation-based tests give early clues about hearing ability before more formal audiology can be done. In suspected COXPD, they often show reduced responses to sound. [12]

8. Developmental screening scales – Standard questionnaires or simple tasks (for example, holding toys, pointing, saying words) are used to check motor, language, and social skills. These manual screens help document developmental delay, which is common in multisystem mitochondrial disease. [4] [5]

Laboratory and pathological tests

9. Blood lactate and pyruvate levels – Elevated lactate, sometimes with abnormal lactate-to-pyruvate ratio, is a hallmark of mitochondrial energy failure. In COXPD34, lactic acidosis is frequently reported and supports the diagnosis of an oxidative phosphorylation defect. [1] [2]

10. Blood glucose testing (including fasting tests) – Measuring blood sugar levels can detect episodes of hypoglycemia. Recurrent hypoglycemia in a child with deafness and lactic acidosis suggests a systemic mitochondrial disease like COXPD34 and requires careful emergency planning. [1]

11. Liver function tests (LFTs) – Tests such as ALT, AST, bilirubin, albumin, and clotting profile show how well the liver is working. Elevated enzymes or poor synthetic function indicate hepatic involvement in the disease, which fits the classic COXPD34 description. [1] [2]

12. Kidney function tests and urinalysis – Blood urea, creatinine, electrolytes, and urine tests (protein, sediment) are used to evaluate kidney damage. Progressive renal impairment is part of the syndromic picture and helps distinguish this disease from isolated mitochondrial deafness. [1]

13. Metabolic screening (amino acids, acylcarnitine profile, organic acids) – Specialized laboratory panels look for patterns seen in mitochondrial and other metabolic diseases. While not specific for COXPD34, abnormal patterns strengthen the suspicion of a generalized metabolic disorder and guide further genetic testing. [4]

14. Mitochondrial respiratory chain enzyme analysis (often in muscle or liver biopsy) – In some centers, a small tissue sample is examined to measure the activity of respiratory chain complexes. Combined reduction in complexes I, III, and IV supports the diagnosis of a combined oxidative phosphorylation deficiency. [4] [7]

15. Targeted or panel-based genetic testing (including MRPS7 sequencing) – Sequencing of specific genes known to cause mitochondrial deafness and COXPD (for example MRPS7, PRORP and others) is now a key diagnostic tool. Many laboratories offer deafness gene panels that include mitochondrial nuclear genes; identifying a biallelic MRPS7 variant confirms COXPD34 [3] [11].

Electrodiagnostic tests

16. Pure tone audiometry – For older children and adults, pure tone audiometry measures hearing thresholds at different frequencies. In COXPD-related deafness, it shows bilateral sensorineural hearing loss, often affecting high frequencies first. This test quantifies the degree of hearing loss and helps plan hearing aids or implants [4] [12].

17. Auditory brainstem response (ABR) testing – ABR uses clicks or tones and surface electrodes to study how sound signals travel along the auditory nerve and brainstem. It is especially useful in infants or uncooperative children. In sensorineural hearing loss, ABR thresholds are elevated or absent, confirming inner ear or nerve damage [12].

18. Otoacoustic emissions (OAE) – OAE testing measures tiny sounds produced by healthy outer hair cells in the cochlea. In many mitochondrial deafness cases, OAEs are reduced or absent, showing hair cell dysfunction. This test is quick, painless, and widely used in newborn hearing screening [4] [5].

19. Electrocardiogram (ECG) – Some mitochondrial diseases involve the heart’s electrical system or muscle. An ECG can pick up conduction problems or rhythm disturbances. Although not specific for COXPD34, it is part of a full screening to detect multisystem involvement and guide safe treatment. [4]

Imaging tests

20. Brain MRI and abdominal ultrasound (liver and kidneys) – Brain MRI looks for structural changes, such as white matter abnormalities, basal ganglia changes, or brain atrophy, which can appear in mitochondrial diseases. Abdominal ultrasound evaluates the size and structure of the liver and kidneys, helping confirm organ enlargement or damage mentioned in the COXPD34 description [1] [7].

Non-pharmacological treatments (therapies and other approaches)

1. Early fitting of digital hearing aids

For children or adults who still have some hearing, modern digital hearing aids can boost sounds, especially speech, so the brain can learn to understand them better. The devices are fitted and adjusted by an audiologist. Fitting them as early as possible supports language development, school performance and social life. Hearing aids do not fix the damaged inner ear, but they amplify sound and improve access to everyday communication and environmental noises.

2. Cochlear implants

When hearing loss is very severe, cochlear implants can be offered. A cochlear implant is a small electronic device surgically placed in the inner ear; an external sound processor sends electrical signals directly to the hearing nerve, bypassing the damaged hair cells. Over time, and with therapy, many people learn to understand speech much better and can use the telephone, go to school, and interact more easily. It does not restore normal hearing but can be life-changing.

3. Bone-anchored and other assistive hearing devices

Bone-anchored hearing systems and other assistive devices (like FM systems in classrooms) can help when anatomy or other issues make standard hearing aids less effective. These devices send sound vibrations through the skull bones or directly to the inner ear, improving speech understanding in noisy places such as classrooms. They are usually combined with hearing aids or implants to improve overall listening.

4. Speech and language therapy

Speech and language therapists design training programs to help children and adults with hearing loss develop listening, speaking, and sometimes sign language skills. Therapy includes exercises for sound discrimination, vocabulary building, sentence understanding, and clear speech production. When therapy starts early and families join sessions, children often reach much better communication and learning outcomes, even with serious hearing loss.

5. Sign language and visual communication

For some families, learning a national sign language and using gestures, facial expressions, and written communication is very important. Sign language gives the child a full, rich language they can use even if hearing aids or implants are not enough. It helps emotional development and avoids isolation. Many experts support “total communication,” combining speech, listening, signs, and pictures to match the child’s needs.

6. Family education and counseling

Parents, siblings, and caregivers need clear information about the disease, expected symptoms, and realistic goals of treatment. Counseling helps them cope with grief, guilt, and fear, and teaches strategies to support communication at home (for example, facing the child when speaking, using short sentences, and quiet rooms). Well-informed families make better choices about surgeries, devices, schooling and nutrition.

7. Individualized education plans and school support

Children with syndromic deafness often need support at school, such as seating near the teacher, classroom microphones, extra time for tests, captioned videos, and teachers trained in deaf awareness. An individualized education plan helps set realistic goals and ensure the child receives speech therapy, special education, or sign language support. Good school adaptation has a strong impact on long-term independence.

8. Physical and occupational therapy

Because COXPD can cause muscle weakness, coordination problems, or developmental delay, physiotherapists and occupational therapists provide exercises to improve strength, balance, posture, and daily living skills. They may recommend walkers, wheelchairs, or orthotic devices if needed. Gentle, regular activity also supports mitochondrial health and reduces fatigue when carefully adapted to the child’s limits.

9. Nutritional assessment and feeding support

Feeding and growth can be a problem in mitochondrial disorders due to fatigue, swallowing issues, or vomiting. Dietitians calculate calorie and protein needs, suggest frequent small meals, and adapt textures for swallowing safety. For some children, special formulas or tube feeding provide reliable nutrition. Stable nutrition helps the body cope better with infections and metabolic stress.

10. Avoidance of fasting and metabolic stress

In mitochondrial disease, long periods without food can worsen lactic acidosis and trigger metabolic crises. Families are often advised to avoid prolonged fasting, especially during illness, and to give extra fluids and carbohydrates when the child is sick. Emergency “sick day” plans may include early hospital evaluation if vomiting, fever, or breathing problems start.

11. Vaccination and infection prevention

Because severe infections can quickly overload weak mitochondria, up-to-date routine vaccines and sometimes extra vaccines (like flu and pneumonia shots) are recommended. Good handwashing, quick treatment of fevers, and early medical review for chest, ear, or urinary infections reduce hospital admissions and organ stress.

12. Psychological support and peer groups

Living with lifelong deafness and a rare metabolic disease is emotionally heavy for both the child and family. Psychologists, social workers, and peer support groups help families share feelings, learn coping skills, and fight stigma. This kind of support reduces anxiety and depression and can improve treatment adherence and quality of life.

13. Genetic counseling for family planning

Genetic counselors explain inheritance patterns, carrier testing, and options for future pregnancies, such as prenatal diagnosis or preimplantation genetic testing. This helps parents understand recurrence risk and make informed reproductive decisions. It can also inform other family members who might be carriers.

14. Environmental noise control and listening strategies

Simple changes like reducing background noise, using carpets and curtains, and turning off TVs during conversation can greatly improve hearing and communication. Teaching the child and family to use good lighting, face-to-face communication, and clear turn-taking reduces listening fatigue and misunderstandings.

15. Regular audiology follow-up

Hearing in mitochondrial disease can change over time. Regular hearing tests help the audiologist adjust devices, decide when to consider implants, and check both ears separately. Early detection of changes means earlier action and better long-term speech and language outcomes.

16. Sleep and fatigue management

Good sleep hygiene (regular bedtime, quiet dark room, limited screens) is important because poor sleep increases fatigue and cognitive problems. Doctors may also look for sleep-disordered breathing or seizures in sleep, which are more common in neurological diseases, and treat them if present.

17. Physical activity within safe limits

Carefully chosen low-to-moderate intensity exercise, like walking, swimming, or gentle cycling, can improve stamina, mood, and muscle function in some mitochondrial patients. Activity must be paced with rest, and strenuous over-exertion should be avoided to prevent energy “crashes.” Plans are best designed by a physiotherapist familiar with mitochondrial disease.

18. Protection against ototoxic medicines and loud noise

Medicines known to damage the inner ear, such as some aminoglycoside antibiotics and certain chemotherapy drugs, should be avoided or used with extreme caution if alternatives exist. Loud noise exposure (very loud music, fireworks, industrial noise) should be minimized to protect any remaining hearing.

19. Assistive communication technology

Text messaging, captioned phone services, real-time speech-to-text apps, and visual alarms (for doorbells or smoke detectors) help deaf or hard-of-hearing people stay safe and communicate easily. These tools can be especially important when fatigue or illness makes listening harder.

20. Social and disability support services

Access to disability benefits, transportation support, special education services, and workplace adaptations can greatly reduce daily stress. Social workers often help families navigate government systems and non-profit resources so that the child or adult can access therapy, devices and inclusive activities.

Drug treatments (general overview and important examples)

Important safety note: For COXPD and most mitochondrial disorders, there is no specific FDA-approved drug that cures the disease. Many medicines described below are used off-label to support energy metabolism or treat symptoms. Exact drug choices, doses and timing must always be set by a specialist. Never start, stop or change any medicine without your doctor, especially in children.

Below are examples of 20 drug or drug-class options commonly discussed in mitochondrial care and syndromic deafness. Many labels and safety data are available on the U.S. Food and Drug Administration website (accessdata.fda.gov), but they are not specifically approved for COXPD; they are used based on general mitochondrial disease experience.

Because of length limits, I will describe some key drugs in more detail and then group some into classes.

1. Levocarnitine (Carnitor and generics)

Levocarnitine is a carrier molecule that helps move long-chain fatty acids into mitochondria so they can be burned for energy. In inborn errors causing secondary carnitine deficiency, the FDA label indicates it for acute and chronic treatment and for deficiency in dialysis patients. Typical oral doses in metabolic diseases are often divided several times per day, based on weight, but must be individualized. Main side effects are gastrointestinal upset, fishy body odor, and rarely seizures in predisposed patients.

2. Coenzyme Q10 (ubiquinone)

Coenzyme Q10 is a fat-soluble antioxidant and key part of the electron transport chain. In primary CoQ10 deficiency, high-dose supplementation can improve symptoms, and CoQ10 has been widely used in other mitochondrial disorders although strong trial data are limited. Doses vary (often 5–30 mg/kg/day divided), and absorption is better with fatty food. Side effects are usually mild, such as stomach upset or headache. CoQ10 is usually considered a dietary supplement rather than a drug in many countries.

3. Riboflavin (vitamin B2)

Riboflavin is a water-soluble B vitamin that forms part of flavoproteins in complex I and II of the respiratory chain. In some flavoprotein-related mitochondrial disorders, riboflavin can clearly improve symptoms; for other mitochondrial diseases, it is used as part of a “cocktail” because it may support residual enzyme activity. Doses are usually much higher than normal dietary needs and given several times daily. Side effects are minimal, most commonly bright yellow urine.

4. Thiamine (vitamin B1)

Thiamine is a cofactor for enzymes in carbohydrate metabolism. In specific disorders like pyruvate dehydrogenase deficiency, high-dose thiamine can be very helpful; in broader mitochondrial disease it may support energy pathways. It is usually given orally one to three times a day in doses above the normal vitamin requirement. Side effects are rare; some people may have mild stomach upset or allergy at very high doses or in injections.

5. Alpha-lipoic acid

Alpha-lipoic acid is an antioxidant and cofactor in mitochondrial enzyme complexes. It may help reduce oxidative stress in mitochondrial disorders, though strong pediatric evidence is limited. It is usually given orally with meals; side effects can include nausea, skin rash, or low blood sugar, especially in children, so medical supervision is essential.

6. Arginine and citrulline

L-arginine and citrulline are amino acids that support nitric oxide production and blood vessel function. In some mitochondrial stroke-like syndromes, arginine infusions or high oral doses can reduce attack severity. In other mitochondrial diseases they may improve blood flow and energy delivery to tissues, but data are limited. Side effects can include nausea, diarrhea, and low blood pressure at high doses.

7. Folinic acid

Folinic acid is an active form of folate used when mitochondrial disease involves cerebral folate deficiency. Supplementation may improve seizures, movement problems, and development in those specific cases. It is usually given orally or by injection; side effects are uncommon but can include gastrointestinal upset or allergic reactions.

8. Creatine monohydrate

Creatine helps store and quickly release energy in muscles and brain. Supplementation has been studied in mitochondrial myopathies to improve strength and fatigue, with mixed results. It is usually taken orally in divided doses; side effects include weight gain from water retention and, rarely, kidney strain if taken in very high doses or with dehydration.

9. Antiseizure medications (for comorbid epilepsy)

Some people with COXPD develop seizures. Medicines like levetiracetam or lamotrigine are often preferred because they are less likely to damage mitochondria, compared with drugs such as valproate which are usually avoided in mitochondrial disease. Doses depend on age, weight, and seizure type. Side effects can include sleepiness, mood changes, or rash, so close neurology follow-up is essential.

10. Corticosteroids (for specific inflammatory complications)

Short courses of corticosteroids such as prednisolone may occasionally be used when there is associated inflammation, for example in autoimmune inner ear disease or sudden hearing loss. They are not used to treat the mitochondrial defect itself. Side effects include weight gain, mood change, higher infection risk, and high blood sugar; long-term use is generally avoided in mitochondrial disease if possible.

11–20. Other frequently considered drug or drug-class options

Because of space limits, the following are listed more briefly. They are used case-by-case, not routinely for every person:

• 11. Multivitamin with B-complex – broad support of vitamin-dependent enzymes.

• 12. Vitamin C and E – antioxidant vitamins sometimes added to cocktails.

• 13. Vitamin K – for coagulation support if liver function is affected.

• 14. Sodium bicarbonate or citrate – to help manage metabolic acidosis.

• 15. Anti-emetic drugs – to control vomiting during metabolic decompensation.

• 16. Proton pump inhibitors or H₂ blockers – to protect stomach lining when many medicines are used.

• 17. Insulin or glucose infusions – during acute crises to maintain blood sugar.

• 18. Pain medicines chosen with mitochondrial safety in mind – for chronic pain or headaches.

• 19. Antibiotics carefully selected to avoid ototoxic drugs – for infections.

• 20. Medications for spasticity or movement disorders – such as baclofen, as individually needed.

All of these require specialist supervision and careful risk–benefit discussion.

Dietary molecular supplements (10 examples)

Many “mitochondrial cocktail” components are actually dietary or molecular supplements rather than registered drugs. Evidence is mixed, so they should always be used with a doctor and dietitian.

1. Coenzyme Q10 – already described above; typical total daily dose often 5–30 mg/kg with food; aims to support electron transport and act as antioxidant.

2. Riboflavin (B2) – supports complex I and II; given in high oral doses; rarely causes harm.

3. Thiamine (B1) – supports carbohydrate metabolism; high doses used in some mitochondrial and energy disorders.

4. Alpha-lipoic acid – antioxidant cofactor; may reduce oxidative stress but needs careful dosing.

5. L-carnitine – helps fatty acid transport; especially when blood carnitine is low.

6. Creatine monohydrate – supports muscle energy buffer; used mainly in older children or adults.

7. L-arginine – supports nitric oxide and blood flow; more evidence in stroke-like syndromes.

8. L-citrulline – sometimes combined with arginine for similar reasons.

9. Folinic acid or methylfolate – supports folate-dependent pathways, especially in cerebral folate deficiency.

10. Antioxidant vitamins C and E combined – may help neutralize free radicals made by damaged mitochondria.

For each supplement, doctors choose a dose based on age, weight and kidney or liver function, and monitor for side effects and changes in labs.

Immunity-booster, regenerative and stem-cell–related drugs (6 points of current knowledge)

For COXPD-related deafness, there are no established immune-booster or stem-cell drugs approved as standard therapy. What exists is mostly experimental:

1. Antioxidant “neuroprotective” molecules (e.g., idebenone, EPI-743/vatiquinone) – studied in some mitochondrial and neurodegenerative diseases to protect cells from oxidative damage; not proven for COXPD deafness and usually only available in trials or special programs.

2. High-dose CoQ10 / ubiquinol – sometimes described as “regenerative” because of antioxidant effects, but really a supplement, not a stem-cell drug.

3. Growth factor–based approaches – research is exploring molecules that support hair-cell or nerve survival in the cochlea; still experimental.

4. Gene therapy for mitochondrial or nuclear genes – trials exist for some mitochondrial conditions, but not yet routine for COXPD with deafness.

5. Stem-cell therapy for inner ear repair – being studied in animals and early human work; at present not proven and should only be considered within ethical clinical trials.

6. Immune-modulating drugs – such as immunoglobulin or biologics, used only if a separate autoimmune disease is present; not standard for COXPD alone.

Families should be very cautious about “stem-cell clinics” or “immune boosters” advertised online without strong evidence, as these can be expensive, ineffective, or even dangerous.

Surgeries (5 examples and why they are done)

1. Cochlear implant surgery – done to place the implant’s electrode array into the cochlea for severe or profound sensorineural deafness. This can greatly improve access to sound and speech, especially when done early, followed by auditory therapy.

2. Bone-anchored hearing device surgery – implants a small device into the skull bone behind the ear, used when standard hearing aids are not possible or effective; improves hearing by bone conduction.

3. Feeding tube (gastrostomy) placement – for children with severe feeding problems, reflux, or risk of aspiration. A tube into the stomach allows safe, reliable nutrition and medication delivery.

4. Orthopedic surgeries – such as tendon releases or spine surgery, occasionally used if severe contractures or scoliosis develop due to muscle weakness; aim to improve comfort, sitting, or walking.

5. Liver transplantation – in very rare cases with severe, isolated liver failure due to mitochondrial disease where transplant may improve survival; decisions must be made by a highly experienced transplant and mitochondrial team.

Ten ways to prevent complications and protect health

1. Avoid prolonged fasting; follow sick-day plans.

2. Keep vaccinations updated and treat infections quickly.

3. Avoid known ototoxic and mitochondria-toxic medicines when possible.

4. Protect ears from loud noises and use hearing protection.

5. Maintain regular moderate activity with rest, avoiding over-exertion.

6. Ensure good nutrition and hydration, including during illness.

7. Attend regular follow-ups with metabolic, audiology, and rehab teams.

8. Have an emergency letter describing the mitochondrial diagnosis for use in hospitals.

9. Plan safe anesthesia with teams experienced in mitochondrial disease if surgery is needed.

10. Seek early help for mood, learning, or behavior problems instead of waiting.

When to see a doctor urgently

People with COXPD-related deafness should seek urgent medical care if they have any of these:

• Fast or difficult breathing, blue lips, or severe tiredness.

• Persistent vomiting or inability to keep fluids down.

• High fever with unusual sleepiness, confusion, or seizures.

• Sudden change in hearing, vision, balance, or strength.

• New or rapidly worsening jaundice (yellow eyes or skin) or very dark urine.

They should also see their regular specialists promptly if school performance, development, behavior, or hearing slowly worsens, or if there are new problems with feeding, growth, or movement.

Diet: what to eat and what to avoid (general guidance)

In mitochondrial disease, diet aims to provide steady energy without long gaps. Many teams suggest frequent, balanced meals with complex carbohydrates, lean protein, and healthy fats. Foods like whole grains, fruits, vegetables, fish, eggs, and dairy (if tolerated) give vitamins, minerals, and antioxidants that support general health. A dietitian can adjust the plan for growth, liver or kidney function, and any swallowing issues.

Things often limited or avoided include long periods without food, crash diets, extreme high-fat or high-protein diets without supervision, very high doses of unproven herbal “energy boosters,” and alcohol in older patients. For children, sugary drinks are usually limited but not fully removed, because simple carbohydrates may be needed during illness under medical guidance. All major changes must be agreed with the metabolic team.

Frequently asked questions (15 FAQs)

1. Is there a cure for syndromic sensorineural deafness due to COXPD?

At the moment, there is no medicine or surgery that completely corrects the underlying mitochondrial defect. Treatment focuses on hearing devices, rehabilitation, nutrition, and mitochondrial cocktails that may help some symptoms. Research on gene therapy and new drugs is active, but nothing is yet proven to cure this specific condition.

2. Can hearing improve over time?

In many children, sensorineural deafness is permanent and can slowly worsen. However, hearing function with devices can improve greatly as the brain learns to use hearing aids or cochlear implants. Early use of these technologies and strong speech therapy make a big difference in language and school performance.

3. Is it safe to use cochlear implants in mitochondrial disease?

Many people with mitochondrial disorders and severe hearing loss have received cochlear implants. Surgery and anesthesia carry some extra risks, so careful pre-operative evaluation is needed. When done by experienced teams with good follow-up, implants can significantly improve communication and quality of life.

4. Do mitochondrial cocktails really work?

Studies show mixed results. For some conditions, such as primary CoQ10 deficiency, specific supplements clearly help. For broader mitochondrial diseases, including many COXPD cases, evidence is weaker and often based on small, uncontrolled studies. Still, many specialists use cocktails because side effects are usually mild and some patients report better energy or fewer crises.

5. Can diet alone treat this disease?

Diet is very important, but it cannot correct the genetic problem. Good nutrition supports growth and reduces the risk of metabolic crashes, but it must be combined with hearing care, rehabilitation, monitoring, and sometimes medicines. Extreme or unbalanced diets without medical advice can actually be dangerous in mitochondrial disease.

6. Are stem-cell clinics for deafness or mitochondrial disease recommended?

At present, stem-cell therapies for hearing loss or COXPD are experimental. They should only be used within high-quality clinical trials approved by ethics committees. Commercial clinics that promise cures without strong data can expose patients to serious risks and high costs without proven benefit.

7. Will my other children have the same disease?

Because COXPD forms linked to genes like MRPS7 are usually autosomal recessive, each full sibling of an affected child has a 25% chance of being affected, a 50% chance of being a carrier, and a 25% chance of being unaffected and not a carrier. Genetic counseling and testing are essential to clarify the risk in each family.

8. Can adults with this condition live independently?

Outcomes vary widely. Some people mainly have hearing loss and can live quite independently with implants, hearing aids, and support. Others have more severe organ involvement and may need lifelong assistance. Early rehabilitation, good nutrition, and careful medical follow-up improve the chances of better function and independence.

9. What medicines should usually be avoided?

Commonly avoided drugs in mitochondrial disease include valproic acid, certain aminoglycoside antibiotics, and some chemotherapy agents because they can worsen mitochondrial function or hearing. However, sometimes benefits may outweigh risks. Lists of safer and less safe drugs should be reviewed with the metabolic and neurology team before starting new medicines.

10. How often should hearing be checked?

In early childhood, hearing is often checked several times a year, especially after fitting aids or implants. In older children and adults with stable hearing, yearly tests may be enough unless new symptoms appear. After big infections or medication changes, extra testing may be needed.

11. Can physical exercise make the disease worse?

Very hard exercise that leaves a person exhausted or sick can stress mitochondria. However, carefully planned moderate activity, balanced with rest, usually helps strength, stamina, and mood. The key is to avoid “boom and bust” patterns and follow a plan made with a physiotherapist who understands mitochondrial disease.

12. Is school in a mainstream setting possible?

Many children with deafness and mitochondrial disease can attend mainstream schools with appropriate supports such as FM systems, teacher training, and extra time for tasks. Some may benefit from special schools for the deaf or mixed settings. The right choice depends on hearing level, other disabilities, and family preference.

13. Can pregnancy be safe for someone with this condition?

Pregnancy in a person with significant mitochondrial disease needs close monitoring by high-risk obstetric and metabolic teams. It can be possible, but there are higher risks of fatigue, organ stress, and complications. Pre-pregnancy counseling is important to discuss maternal health and genetic recurrence risks.

14. How can we protect mental health in the family?

Regular psychological support, participation in peer groups, open discussion of feelings, and respite care can protect mental health. Encouraging independence, celebrating small achievements, and connecting with other families facing similar challenges all help reduce isolation and stress.

15. Where can we find reliable information?

Reliable information usually comes from mitochondrial disease foundations, national deafness organizations, academic hospital websites, and peer-reviewed articles. Your care team can suggest trustworthy resources and warn against misleading online claims or miracle cures. Always cross-check serious decisions with your specialist.

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: February 25, 2025.